Showing results (1201-1210 of 1,373) with videos related to

Sort By:
Pageof 138
International Journal of Clinical Pharmacology and Therapeutics|December 24, 1997
Influence of acute renal failure on FPIA rapid serum assay of midazolam and its main metaboliteV Bouton, P Bourget, A Lesne-Hulin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 2009
Breast cancer with synchronous metastases: survival impact of exclusive locoregional radiotherapyRomuald Le Scodan, Denise Stevens, Etienne Brain, et al.
BMC Bioinformatics|August 23, 2013
The GMOseek matrix: a decision support tool for optimizing the detection of genetically modified plantsAnnette Block, Frédéric Debode, Lutz Grohmann, et al.
Journal of Translational Medicine|December 15, 2015
HERC5 is a prognostic biomarker for post-liver transplant recurrent human hepatocellular carcinomaFeng Xue, Brandon W Higgs, Jiaqi Huang, et al.
Cell Reports|May 18, 2024
Unraveling hallmark suitability for staging pre- and post-implantation stem cell modelsConstance Onfray, Simon Chevolleau, Eva Moinard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 9, 2010
Bortezomib plus dexamethasone is superior to vincristine plus doxorubicin plus dexamethasone as induction treatment prior to autologous stem-cell transplantation in newly diagnosed multiple myeloma: results of the IFM 2005-01 phase III trialJean-Luc Harousseau, Michel Attal, Hervé Avet-Loiseau, et al.
Environment International|June 25, 2018
Pregnancy exposure to atmospheric pollution and meteorological conditions and placental DNA methylationEmilie Abraham, Sophie Rousseaux, Lydiane Agier, et al.
Haematologica|December 3, 2011
Thalidomide versus dexamethasone for the treatment of relapsed and/or refractory multiple myeloma: results from OPTIMUM, a randomized trialMartin Kropff, Honorata Giongco Baylon, Jens Hillengass, et al.
Pageof 138